ÂÜÀòÂÒÂ×

Dr. Francois Vandenhende is the founder and CEO of ClinBAY, a statistical CRO that delivers cost-effective quantitative solutions to pharmaceutical decision makers. Dr. Vandenhende is a clinical statistician, specialized in Bayesian methods and adaptive designs. He provides statistical insight into scientific advisory boards for various biotech companies. He is also managing strategic alliances for ClinBAY with several global pharmaceutical customers. Prior to joining ClinBAY, Francois started his career at Merck for 1 year, then moved to Eli Lilly and Company for 14 years, where he ended as the global head of CNS early phase statistics. He has a Ph.D. degree in statistics from UCL, Belgium.